Dermal Allograft Innovation Grants

Allograft dermal matrices (ADMs) and skin allografts are widely used in reconstructive and regenerative procedures, including breast surgery, wound healing, and abdominal wall reconstruction. Current applications primarily rely on sheet-based products. However, there is an increasing need for innovative technologies that expand the versatility of ADM and skin, increase clinical utility, improve storage and handling, and enable new clinical applications. Emerging concepts such as flowable or particulate ADM, 3D printed constructs, tissue-engineered skin, viable dermal tissues, and advanced preservation technologies represent transformative opportunities for patient care.

MTF Biologics invites Translational and Clinical Research proposals that accelerate innovation in allograft dermis and skin by developing new enabling technologies, novel clinical uses, advanced processing or delivery methods, and next generation product forms.

Innovation in Allografts Translational Grants

This program supports high‑impact translational and clinical research that advances allograft tissue science and improves patient outcomes. Proposed research must utilize allograft tissues or allograft‑derived materials and include a clear, credible pathway toward clinical translation. Projects focused solely on autologous, synthetic‑only, or non‑allograft‑centered technologies are out of scope.

Clinical areas of interest include orthopaedics, plastic and reconstructive surgery, aesthetics, surgical soft‑tissue repair, abdominal wall reconstruction, and wound care, as well as any other specialty area where allograft transplantation technologies can drive meaningful improvement.